Discuva gets £1.5m to support antibiotics development
Cambridge, UK-based drug discovery group Discuva has been awarded £1.5 million of Biomedical Catalyst* money to support development of novel antibiotics to tackle the issue of multidrug-resistance and life-threatening bacterial infections.
Read More
